Lausanne Branch, Ludwig Institute for Cancer Research, 1011 Lausanne, Switzerland; Agora Cancer Research Center, 1011 Lausanne, Switzerland; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland; Swiss Cancer Center, Leman (SCCL), 1011 Lausanne, Switzerland.
Department of Neurology and Neurological Sciences, Stanford University, Stanford, Stanford, CA, USA; Howard Hughes Medical Institute, Stanford University, Stanford, CA, USA.
Cancer Cell. 2023 Mar 13;41(3):573-580. doi: 10.1016/j.ccell.2023.02.012.
The mechanisms underlying the multistep process of tumorigenesis can be distilled into a logical framework involving the acquisition of functional capabilities, the so-called hallmarks of cancer, which are collectively envisaged to be necessary for malignancy. These capabilities, embodied both in transformed cancer cells as well as in the heterotypic accessory cells that together constitute the tumor microenvironment (TME), are conveyed by certain abnormal characteristics of the cancerous phenotype. This perspective discusses the link between the nervous system and the induction of hallmark capabilities, revealing neurons and neuronal projections (axons) as hallmark-inducing constituents of the TME. We also discuss the autocrine and paracrine neuronal regulatory circuits aberrantly activated in cancer cells that may constitute a distinctive "enabling" characteristic contributing to the manifestation of hallmark functions and consequent cancer pathogenesis.
肿瘤发生的多步骤过程的机制可以归结为一个逻辑框架,其中包括获得功能能力,即所谓的癌症特征,这些特征被认为是恶性肿瘤所必需的。这些能力既体现在转化的癌细胞中,也体现在共同构成肿瘤微环境(TME)的异质辅助细胞中,是由癌症表型的某些异常特征传递的。本观点讨论了神经系统与标志性能力诱导之间的联系,揭示了神经元和神经元突起(轴突)作为 TME 中诱导标志性特征的组成部分。我们还讨论了癌细胞中异常激活的自分泌和旁分泌神经元调节回路,这些回路可能构成一个独特的“使能”特征,有助于标志性功能的表现和随后的癌症发病机制。
Cancer Cell. 2023-3-13
Cancer Discov. 2022-1
Acta Biochim Biophys Sin (Shanghai). 2023-6-9
Cell. 2011-3-4
Adv Exp Med Biol. 2016
Cancer Cell. 2012-3-20
Cancer Treat Rev. 2018-2-22
J Zhejiang Univ Sci B. 2017-5
Pharmaceuticals (Basel). 2025-8-13
Br J Cancer. 2025-8-26
Lancet Digit Health. 2025-8-8
Nature. 2023-11
Nat Cell Biol. 2022-10
Adv Biol (Weinh). 2022-9
Cancer Discov. 2022-10-5
Annu Rev Neurosci. 2022-7-8
Cancer Discov. 2022-1